APP and Alzheimer disease: Given that reduced activity was caused by both Hexb heterozygosity and App knock-in mutations and there was no additive effect when these mutations were combined, it is possible that the familial AD mutations in the AppKI/KI mice and Hexb heterozygosity affect activity via the same pathway.